Deerfield Management Company »

Embecta Corporation shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Embecta Corporation (EMBC) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Embecta Corporation

Tip: Access up to 7 years of quarterly data

All positions including Embecta Corporation held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Embecta Corporation by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $26M 1.4M 18.93

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Embecta Corporation

Vanguard Group
Millennium Management
River Road Asset Management
Yacktman Asset Management
Henderson Group
Deerfield Management Company
Charles Schwab Investment Management
Balyasny Asset Management
Bank of New York Mellon
D. E. Shaw & Co
Citadel Advisors
Goldman Sachs Group
First Eagle Investment Management
Dimensional Fund Advisors
Point72 Asset Management

View all funds holding Embecta Corporation